Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) EBT (2020 - 2026)

Treace Medical Concepts filings provide 6 years of EBT readings, the most recent being -$6.7 million for Q4 2025.

  • On a quarterly basis, EBT fell 989.66% to -$6.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$56.7 million, a 1.12% decrease, with the full-year FY2025 number at -$56.7 million, down 1.12% from a year prior.
  • EBT hit -$6.7 million in Q4 2025 for Treace Medical Concepts, up from -$16.4 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$619000.0 in Q4 2024 to a low of -$21.3 million in Q2 2024.
  • Median EBT over the past 5 years was -$12.2 million (2022), compared with a mean of -$11.1 million.
  • Biggest five-year swings in EBT: soared 90.29% in 2024 and later plummeted 989.66% in 2025.
  • Treace Medical Concepts' EBT stood at -$6.6 million in 2021, then surged by 38.75% to -$4.1 million in 2022, then tumbled by 57.26% to -$6.4 million in 2023, then soared by 90.29% to -$619000.0 in 2024, then plummeted by 989.66% to -$6.7 million in 2025.
  • The last three reported values for EBT were -$6.7 million (Q4 2025), -$16.4 million (Q3 2025), and -$17.5 million (Q2 2025) per Business Quant data.